Filed: 11/14/2022ACC: 0000921895-22-003040
π What this filing means
MEMORIAL SLOAN KETTERING CANCER CENTER filed this quarterly 13FβHR report disclosing 5 equity positions with a total reported market value of $29.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$29.4K
Total AUM (reported)
2.08M
Total Shares
Allocation by class
GOLD MINERS ETF$17.8K60.6%
COM$11.6K39.4%
Portfolio Concentration
Top 3$26.3K89.4%
4β10$3.1K10.6%
Top 3 weight
89.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.08M
Sole
Full voting authority
2.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings5
Rows:
VANECK ETF TRUST
SOLEShares738.50K
TypeSH
Market value$17.8K
60.55%
Sole
738.50K
Shared
0.00
None
0.00
CARIBOU BIOSCIENCES INC
SOLEShares544.20K
TypeSH
Market value$5.7K
19.52%
Sole
544.20K
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares191.18K
TypeSH
Market value$2.8K
9.37%
Sole
191.18K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares602.27K
TypeSH
Market value$1.9K
6.55%
Sole
602.27K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares6.19K
TypeSH
Market value$1.2K
4.01%
Sole
6.19K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VANECK ETF TRUSTSOLE | GOLD MINERS ETF | 738.50K | SH | $17.8K 60.55% | 738.50K | 0.00 | 0.00 |
CARIBOU BIOSCIENCES INCSOLE | COM | 544.20K | SH | $5.7K 19.52% | 544.20K | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 191.18K | SH | $2.8K 9.37% | 191.18K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 602.27K | SH | $1.9K 6.55% | 602.27K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 6.19K | SH | $1.2K 4.01% | 6.19K | 0.00 | 0.00 |